PUMA BIOTECHNOLOGY, INC. financial data

Symbol
PBYI on Nasdaq
Location
Los Angeles, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 174% % 22%
Quick Ratio 9.8% % 46%
Debt-to-equity 81% % -64%
Return On Equity 28% % -40%
Return On Assets 15% % 8.2%
Operating Margin 16% % 22%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50,876,487 shares 2.5%
Common Stock, Shares, Outstanding 50,408,023 shares 2.7%
Entity Public Float $145,200,000 USD 8%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 50,011,485 shares 2.8%
Weighted Average Number of Shares Outstanding, Diluted 50,653,283 shares 3.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $228,371,000 USD -0.91%
Costs and Expenses $191,072,000 USD -4.2%
Operating Income (Loss) $37,299,000 USD 20%
Nonoperating Income (Expense) $1,517,000 USD 78%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $35,782,000 USD 48%
Income Tax Expense (Benefit) $6,178,000 USD -670%
Net Income (Loss) Attributable to Parent $31,111,000 USD 2.8%
Earnings Per Share, Basic 0.62 USD/shares 0%
Earnings Per Share, Diluted 0.61 USD/shares -1.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $29,635,000 USD -57%
Marketable Securities, Current $67,893,000 USD 114%
Cash, Cash Equivalents, and Short-term Investments $91,627,000 USD 5.5%
Accounts Receivable, after Allowance for Credit Loss, Current $53,654,000 USD 68%
Inventory, Net $5,515,000 USD -37%
Other Assets, Current $256,000 USD 181%
Assets, Current $162,686,000 USD 10%
Deferred Income Tax Assets, Net $3,830,000 USD -46%
Property, Plant and Equipment, Net $187,000 USD -64%
Operating Lease, Right-of-Use Asset $5,373,000 USD 17%
Assets $216,302,000 USD 1.4%
Accounts Payable, Current $5,056,000 USD -8.2%
Employee-related Liabilities, Current $5,797,000 USD 33%
Accrued Liabilities, Current $50,031,000 USD 36%
Liabilities, Current $81,253,000 USD -15%
Operating Lease, Liability, Noncurrent $4,709,000 USD 215%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $85,962,000 USD -29%
Accumulated Other Comprehensive Income (Loss), Net of Tax $36,000 USD 500%
Retained Earnings (Accumulated Deficit) $1,283,775,000 USD 2.4%
Stockholders' Equity Attributable to Parent $130,340,000 USD 41%
Liabilities and Equity $216,302,000 USD 1.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,612,000 USD -68%
Net Cash Provided by (Used in) Financing Activities $11,332,000 USD
Net Cash Provided by (Used in) Investing Activities $1,531,000 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 50,408,023 shares 2.7%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $6,189,000 USD 21%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,917,000 USD -34%
Deferred Tax Assets, Valuation Allowance $324,787,000 USD -5.4%
Deferred Tax Assets, Gross $329,982,000 USD -6.2%
Operating Lease, Liability $6,023,000 USD -14%
Depreciation $400,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $61,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $31,141,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid $8,127,000 USD 8.5%
Property, Plant and Equipment, Gross $4,785,000 USD -43%
Operating Lease, Liability, Current $1,314,000 USD -76%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,248,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,913,000 USD -68%
Operating Lease, Weighted Average Discount Rate, Percent 0.122 pure 12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,104,000 USD 360%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,292,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $230,018,000 USD -0.93%
Current Income Tax Expense (Benefit) $1,426,000 USD 59%
Unrecognized Tax Benefits $3,398,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,338,000 USD
Operating Lease, Payments $1,621,000 USD 2.7%
Amortization of Intangible Assets $9,700,000 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $5,195,000 USD -39%
Share-based Payment Arrangement, Expense $6,944,000 USD -16%